Domestic Events + Font Resize -

3rd Biosimilars Congregation to be held on April 18 in Mumbai
Our Bureau, Mumbai | Tuesday, April 2, 2013, 10:00 Hrs  [IST]

The 3rd Biosimilars Congregation 2013 for “Uniting industry leaders to analyse advanced commercial developments & to identify successful management strategies of Biosimilars” will be held on April 18 at Kohinoor Continental Hotel, Mumbai.

The key themes discussed at this conference include:

*How should the pharma and generics industries approach the rapidly emerging and developing biosimilar market & what are the future trends for the biosimilar market?
*Finding the current and future issues in biosimilars & how to build public confidence and interest?
*How to maximise the strategic partnerships to enter into the biosimlar markets
*Analysing the next generation monoclonal antibody development & the clinical challenges with biosimilar drug development
*Identifying the successful development plans for the biosimilars market in India
*What are the considerations and capabilities required for biosimilar product development
*How to overcome challenges in development and commercialization of biosimilars
*What are the regulations and guidance for development and manufacture of biosimilars in India
*Legal/IP for biosimlars
*Identifying the best strategy adopted by global biosimilar companies.
*What originators and follow-n companies need to know?

The key speakers include:Ashima Bhatia, vice president - Global Clinical Research, Wockhardt; Arun Bhatt, president, Clininvent Research; Amanda Gibbons, director, Voisin Consulting Life Sciences (France); Bobby George, assistant vice president and head, regulatory affairs, Reliance Life Sciences; Purnima Sharma, managing director, Biotech Consortium India Limited (BCIL); Nidhi Saxena, president & CEO, Karmic Lifesciences; R H Jani, senior vice president, clinical R&D, Cadila; Annaswamy Vaidheesh, vice president - Government affairs Asia Pacific, Johnson & Johnson; Kaustubh Berde, vice president & head - International Formulations, Panacea Biotec and  Amita Birla, associate director - clinical operation, Karmic Lifesciences.

There will also be  power packed Q&A sessions moderated by chairperson.

For  more  details  call  TEL: +91 44 64536444 or  Email: conferences@virtueinsight.com

Post Your Comment

 

Enquiry Form